Literature DB >> 20405318

Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.

Malay S Gandhi1, German Kamalov, Atta U Shahbaz, Syamal K Bhattacharya, Robert A Ahokas, Yao Sun, Ivan C Gerling, Karl T Weber.   

Abstract

Fibrosis is a fundamental component of the adverse structural remodeling of myocardium present in the failing heart. Replacement fibrosis appears at sites of previous cardiomyocyte necrosis to preserve the structural integrity of the myocardium, but not without adverse functional consequences. The extensive nature of this microscopic scarring suggests cardiomyocyte necrosis is widespread and the loss of these contractile elements, combined with fibrous tissue deposition in the form of a stiff in-series and in-parallel elastic elements, contributes to the progressive failure of this normally efficient muscular pump. Cellular and molecular studies into the signal-transducer-effector pathway involved in cardiomyocyte necrosis have identified the crucial pathogenic role of intracellular Ca2+ overloading and subsequent induction of oxidative stress, predominantly confined within its mitochondria, to be followed by the opening of the mitochondrial permeability transition pore that leads to the destruction of these organelles and cells. It is now further recognized that Ca2+ overloading of cardiac myocytes and mitochondria serves as a prooxidant and which is counterbalanced by an intrinsically coupled Zn2+ entry serving as antioxidant. The prospect of raising antioxidant defenses by increasing intracellular Zn2+ with adjuvant nutriceuticals can, therefore, be preferentially exploited to uncouple this intrinsically coupled Ca2+ - Zn2+ dyshomeostasis. Hence, novel yet simple cardioprotective strategies may be at hand that deserve to be further explored.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20405318      PMCID: PMC2920342          DOI: 10.1007/s10741-010-9169-3

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  114 in total

1.  Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure.

Authors:  Rami N Khouzam; Dwight A Dishmon; Victor Farah; Sherri D Flax; Laura D Carbone; Karl T Weber
Journal:  Am J Med Sci       Date:  2006-01       Impact factor: 2.378

2.  Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-kappaB in up-regulation.

Authors:  K Sandeep Prabhu; Faith Zamamiri-Davis; Jennifer B Stewart; Jerry T Thompson; Lorraine M Sordillo; C Channa Reddy
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

3.  Effect of zinc on acute and chronic isoproterenol induced heart injury.

Authors:  M Chvapil; J A Owen
Journal:  J Mol Cell Cardiol       Date:  1977-02       Impact factor: 5.000

4.  Epinephrine-induced hypokalemia: the role of beta adrenoceptors.

Authors:  J L Reid; K F Whyte; A D Struthers
Journal:  Am J Cardiol       Date:  1986-04-25       Impact factor: 2.778

5.  Serum levels of selenium, calcium, copper magnesium, manganese and zinc in various human diseases.

Authors:  J F Sullivan; A J Blotcky; M M Jetton; H K Hahn; R E Burch
Journal:  J Nutr       Date:  1979-08       Impact factor: 4.798

6.  Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients.

Authors:  P Faure; O Ramon; A Favier; S Halimi
Journal:  Eur J Clin Invest       Date:  2004-07       Impact factor: 4.686

7.  Clinical significance of cardiac troponins I and T in acute heart failure.

Authors:  Tuomo Ilva; Johan Lassus; Krista Siirilä-Waris; John Melin; Keijo Peuhkurinen; Kari Pulkki; Markku S Nieminen; Harri Mustonen; Pekka Porela; Veli-Pekka Harjola
Journal:  Eur J Heart Fail       Date:  2008-07-02       Impact factor: 15.534

Review 8.  Endothelin: potential role in hypertension and vascular hypertrophy.

Authors:  E L Schiffrin
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

9.  Increased malondialdehyde in peripheral blood of patients with congestive heart failure.

Authors:  C R Díaz-Vélez; S García-Castiñeiras; E Mendoza-Ramos; E Hernández-López
Journal:  Am Heart J       Date:  1996-01       Impact factor: 4.749

10.  Reversal of impaired oxidative phosphorylation and calcium overloading in the in vitro cardiac mitochondria of CHF-146 dystrophic hamsters with hereditary muscular dystrophy.

Authors:  S K Bhattacharya; P L Johnson; J H Thakar
Journal:  J Neurol Sci       Date:  1993-12-15       Impact factor: 3.181

View more
  13 in total

1.  Cardiospecific deletion of αE-catenin leads to heart failure and lethality in mice.

Authors:  Volodymyr V Balatskyi; Larysa L Macewicz; Ana-Maria Gan; Sergii V Goncharov; Paulina Pawelec; Georgiy V Portnichenko; Tetiana Yu Lapikova-Bryginska; Viktor O Navrulin; Victor E Dosenko; Adam Olichwier; Pawel Dobrzyn; Oksana O Piven
Journal:  Pflugers Arch       Date:  2018-06-20       Impact factor: 3.657

Review 2.  Roles of SIRT3 in heart failure: from bench to bedside.

Authors:  De-Xing Hu; Xian-Bao Liu; Wen-Chao Song; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2016 Nov.       Impact factor: 3.066

3.  Differences in left ventricular cardiomyocyte loss induced by chronic intermittent hypoxia between spontaneously hypertensive and Wistar-Kyoto rats.

Authors:  Tsung-I Chen; Ching-Jung Lai; Chien-Ju Hsieh; Ke-Li Tsai; Kun-Ta Yang
Journal:  Sleep Breath       Date:  2010-12-07       Impact factor: 2.816

4.  Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis.

Authors:  Grace J Lee; Lin Yan; Dorothy E Vatner; Stephen F Vatner
Journal:  Basic Res Cardiol       Date:  2015-01-20       Impact factor: 17.165

Review 5.  Fibrosis and heart failure.

Authors:  Ana Maria Segura; O H Frazier; L Maximilian Buja
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

Review 6.  Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail.

Authors:  Summer Hassan; Carolyn J Barrett; David J Crossman
Journal:  Biophys Rev       Date:  2020-07-23

7.  Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function.

Authors:  Nathan Y Weltman; Dajun Wang; Rebecca A Redetzke; A Martin Gerdes
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

8.  Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat.

Authors:  Hamid Soraya; Maryam Rameshrad; Aram Mokarizadeh; Alireza Garjani
Journal:  Bioimpacts       Date:  2015-02-21

9.  Proteome analysis of subsarcolemmal cardiomyocyte mitochondria: a comparison of different analytical platforms.

Authors:  Francesco Giorgianni; Diwa Koirala; Karl T Weber; Sarka Beranova-Giorgianni
Journal:  Int J Mol Sci       Date:  2014-05-26       Impact factor: 5.923

Review 10.  Molecular Imaging Using Cardiac PET/CT: Opportunities to Harmonize Diagnosis and Therapy.

Authors:  James T Thackeray
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.